Lv5
1246 积分 2024-08-26 加入
Resting heart rate and risk of hypertension: results of the Kailuan cohort study
3天前
已完结
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis: a nationwide cohort study from the DANBIO and DERMBIO registries
5天前
已完结
Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study
5天前
已完结
Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis
5天前
已完结
Guselkumab Re-Treatment After Withdrawal: Rapid Regain of Disease Control in Super-Responders with Moderate-to-Severe Plaque Psoriasis - Final Week 220 Phase 3b GUIDE Findings
5天前
求助中
Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study
5天前
已完结
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): week 28 results from the ongoing phase IIIb, randomized, double-blind, parallel-group, GUIDE study
5天前
已完结
Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial
5天前
已完结
Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab
5天前
已完结
Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial
5天前
已完结
皖公网安备34019202002308
